Molecular Partners Ag MOLN
NASDAQ MOLN
$4.40 +0.17 (+4.02%)
As of: Aug 21, 2026 · 12:43 PM EDT

Molecular Partners Ag (MOLN) Free Cash Flow (2020 - 2026)

Molecular Partners Ag (MOLN) posted quarterly Free Cash Flow of -$18188.4 for Q1 2026, up 1.68% year-over-year from -$17888.1 in Q1 2025, and up 99.97% quarter-over-quarter from -$65.0 million in Q4 2025.

Molecular Partners Ag (MOLN) Free Cash Flow (2020 - 2026) Analysis & Trends

Molecular Partners Ag (MOLN) has reported Free Cash Flow for 7 consecutive years, with -$18188.4 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Free Cash Flow rose 1.68% year-over-year to -$18188.4; the TTM figure through Mar 2026 stood at -$63.8 million (up 4.63% YoY), while the FY2025 annual figure was -$65.0 million, up 4.99% from the prior year.
  • Free Cash Flow improved to -$18188.4 in Q1 2026 per MOLN's latest filing, from -$65.0 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $157.0 million in Q2 2022 and bottomed at -$156.6 million in Q3 2022.
  • Historically, Free Cash Flow has averaged -$4.4 million across 5 years, with a median of -$18499.0 in 2025.
  • On a YoY basis, Free Cash Flow climbed as much as 633.09% in 2022 and fell as far as 375.79% in 2022.
  • Molecular Partners Ag's Free Cash Flow stood at $121.7 million in 2022, then tumbled by 155.15% to -$67.1 million in 2023, then slipped by 1.89% to -$68.4 million in 2024, then climbed by 4.99% to -$65.0 million in 2025, then soared by 99.97% to -$18188.4 in 2026.
  • Business Quant data shows MOLN's Free Cash Flow at -$18188.4 in Q1 2026, -$65.0 million in Q4 2025, and $37.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.01 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 572.80 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -563.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 437.80 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 292.04 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 433.84 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -95.09 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 477.44 Mn
10 Molecular Partners Ag 163.99 Mn 163.99 Mn - -18,188.38

Historic Data

Download Data
DateValue
Mar 31, 2026 -18,188.38
Mar 31, 2026 -18,188.38
Dec 31, 2025 -64.98 Mn
Dec 31, 2025 -64.98 Mn
Sep 30, 2025 37.00 Mn
Sep 30, 2025 37.00 Mn
Jun 30, 2025 -35.78 Mn
Jun 30, 2025 -35.78 Mn
Mar 31, 2025 -18,498.95
Mar 31, 2025 -18,498.95
Dec 31, 2024 -68.39 Mn
Dec 31, 2024 -68.39 Mn
Sep 30, 2024 37.41 Mn
Sep 30, 2024 37.41 Mn
Jun 30, 2024 -35.87 Mn
Jun 30, 2024 -35.87 Mn
Mar 31, 2024 -19,392.96
Mar 31, 2024 -19,392.96
Dec 31, 2023 -67.12 Mn
Dec 31, 2023 -67.12 Mn